Abstract
Eosinophil and mast cell counts were done in 44 patients with active ulcerative colitis, 10 patients with ulcerative colitis in remission, and 44 matched subjects with functional bowel disorder. Mean (±sd) rectal eosinophil counts (EC) per unit area were significantly high (P<0.01) in active ulcerative colitis (5.80±5.49) as compared with inactive disease (2.81±2.19) or controls (3.01±1.67). Eosinophil count was not significantly different in the acute stage between responder (6.36±5.95) and nonresponders (5.1±5.84) to medical treatment and was thus of little discriminatory and prognostic value. Mean (±sd) EC was reduced from 6.36±5.95 to 3.91±3.19 in responders after four weeks of medical treatment. There was little change in the EC with treatment in nonresponders. No correlation was seen between tissue eosinophils and clinical severity of ulcerative colitis. Mast cell count was not significantly different between patients with active ulcerative colitis, inactive disease, and controls and thus had little diagnostic or prognostic value. It can be concluded therefore, that EC in the rectal mucosa indicated activity but not severity of ulcerative colitis. A reduction in EC possibly indicated remission. Rectal EC, however, cannot correctly prognosticate the treatment response and outcome of the disease.
Similar content being viewed by others
References
Powell-Tuck J, Ritchie JK, Lennard-Jones JE: The prognosis of idiopathic proctitis. Scand J Gastroenterol 12:727–732, 1977
Sharma MP, Sarin SK: Ulcerative colitis in a north Indian hospital: current trends. J R Coll Physicians London 19:99–102, 1985
Sharma MP, Sarin SK, Malviya AN, Karmarker MG: Significance of C-reactive protein in the management of ulcerative colitis. Indian J Med Res 75:858–861, 1982
Surawicz CM, Belic L: Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology 86:104–113, 1984
Binder VA: Comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa and cytologic picture of mucosal exudate in ulcerative colitis. Scand J Gastroenterol 5:627–632, 1970
Scott BB, Goodall A, Stephenson P, Jenkins D: Rectal mucosal plasma cells in inflammatory bowel disease. Gut 24:519–524, 1983
Heatley RV, Calcraft BJ, Rhodes J, Owen E, Evans BK: Disodium chromoglycate in the treatment of chronic proctitis. Gut 16:559–563, 1975
Heatley RV, James PD: Eosinophils in the rectal mucosa: A simple method of predicting the outcome of ulcerative proctocolitis? Gut 20:787–791, 1979
Binder V, Elsborg L, Greibe J, Hendriksen C, Lene HØJ, Birger Jensen K, Kristensen E, Rask Madsen J, Marner B, Riis P, Willumsen L: Disodium chromoglycate in the treatment of ulcerative colitis and Crohn's disease. Gut 22:55–60, 1981
Rosekrans PCM, Meijer CJLM, Vander Wal AM, Cornelisse Lindeman J: Immunoglobulin containing cells in inflammatory bowel disease of the colon; a morphometric and immunohistochemical study. Gut 21:941–947, 1980
Lloyd G, Green PHY, Fox H, Mani V, Turnbeng LA: Mast cells and immunoglobulin E in inflammatory bowel disease. Gut 16:861–866, 1975
O'Donoghue DP, Kumar P: Rectal IgE cells in inflammatory bowel disease. Gut 20:149–153, 1979
Dvorak AM, Monahan RH: Crohn's disease-mast cell quantitation using one micron plastic sections for light microscopic study.In Pathology Annual, Part I. SC Sommers, PP Rosen (eds). Appleton Century Crofts 1983, pp 181–190
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sarin, S.K., Malhotra, V., Gupta, S.S. et al. Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. Digest Dis Sci 32, 363–367 (1987). https://doi.org/10.1007/BF01296289
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296289